3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
49
Gastrointestinal
14
Thoracic
13
Gynecologic
11
Genitourinary
10
Breast
10
Sarcoma
9
CNS
7
Dermatologic
6
Endocrine
5
NET
4
Other solid neoplasm
3
Other hematologic neoplasm
3
Lymphoid
2
Plasma cell
1
Other neoplasm
1
Conditions
Lymphoma
549
Precursor Cell Lymphoblastic Leukemia-Lymphoma
511
Lymphoma, Non-Hodgkin
437
Lymphoma, Follicular
405
Lymphoma, Large B-Cell, Diffuse
392
Leukemia, Lymphocytic, Chronic, B-Cell
392
Lymphoma, B-Cell
248
Lymphoma, Mantle-Cell
224
Hodgkin Disease
209
Recurrence
205
Leukemia, Myeloid, Acute
199
Leukemia
196
Multiple Myeloma
185
Burkitt Lymphoma
185
Lymphoma, B-Cell, Marginal Zone
170
Neoplasms
153
Myelodysplastic Syndromes
134
Hematologic Neoplasms
115
Waldenstrom Macroglobulinemia
103
Lymphoma, T-Cell, Peripheral
86
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
83
Lymphoma, T-Cell
82
Lymphoma, T-Cell, Cutaneous
67
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
63
Mycosis Fungoides
57
Leukemia, Biphenotypic, Acute
55
Breast Neoplasms
55
Leukemia, B-Cell
52
Myeloproliferative Disorders
50
Lymphoproliferative Disorders
47
Interventions
entrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Salivary Gland Neoplasms
×
Lymphoid
×
1 year
×
Clear all
NCT02568267
2026-05-27
STARTRK-2
Hoffmann-La Roche
Phase 2
Active not recruiting
534 enrolled
1 FDA
NCT06582849
2025-08-26
EARN
Washington University School of Medicine
Phase NA
Completed
33 enrolled